NFKB1 and Alzheimer disease: After identifying the biomarkers IL-1β, NF-κB, Akt, and GATA3 as drug targets for AD, a DNN-based DTI model was trained on DTI data from DTI databases to predict molecular drugs for these biomarkers of AD, as described in Section 4.1.